Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Wieslawa Olszewska & Peter Openshaw. (2009) Emerging drugs for respiratory syncytial virus infection. Expert Opinion on Emerging Drugs 14:2, pages 207-217.
Read now
Read now
Hagen Cramer. (2005) Antisense approaches for inhibiting respiratory syncytial virus. Expert Opinion on Biological Therapy 5:2, pages 207-220.
Read now
Read now
Articles from other publishers (11)
Rob Lambkin‐Williams & John P. DeVincenzo. (2020) A COVID‐19 human viral challenge model. Learning from experience. Influenza and Other Respiratory Viruses 14:6, pages 747-756.
Crossref
Crossref
Daljit S. Matharu, Daniel P. Flaherty, Denise S. Simpson, Chad E. Schroeder, Donghoon Chung, Dan Yan, James W. Noah, Colleen B. Jonsson, E. Lucile White, Jeffrey Aubé, Richard K. Plemper, William E. Severson & Jennifer E. Golden. (2014) Optimization of Potent and Selective Quinazolinediones: Inhibitors of Respiratory Syncytial Virus That Block RNA-Dependent RNA-Polymerase Complex Activity. Journal of Medicinal Chemistry 57:24, pages 10314-10328.
Crossref
Crossref
Dong-Hoon Chung, Blake P Moore, Daljit S Matharu, Jennifer E Golden, Clinton Maddox, Lynn Rasmussen, Melinda I Sosa, Subramaniam Ananthan, E Lucile White, Fuli Jia, Colleen B Jonsson & William E Severson. (2013) A cell based high-throughput screening approach for the discovery of new inhibitors of respiratory syncytial virus. Virology Journal 10:1.
Crossref
Crossref
Nicholas A. Meanwell, Stanley V. D'Andrea, Christopher W. Cianci, Ira B. Dicker, Kap-Sun Yeung, Makonen Belema & Mark Krystal. 2013. Drug Discovery. Drug Discovery
439
515
.
Helen Y. Chu & Janet A. Englund. 2013. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines. Challenges and Opportunities for Respiratory Syncytial Virus Vaccines
235
258
.
Blake P. Moore, Dong Hoon Chung, Daljit S. Matharu, Jennifer E. Golden, Clinton Maddox, Lynn Rasmussen, James W. Noah, Melinda I. Sosa, Subramaniam Ananthan, Nichole, A. Tower, E. Lucile White, Fuli Jia, Thomas E. Prisinzano, Jeffrey Aubé, Colleen B. Jonsson & William E. Severson. (2012)
(
S
)-
N
-(2,5-Dimethylphenyl)-1-(quinoline-8-ylsulfonyl)pyrrolidine-2-carboxamide as a Small Molecule Inhibitor Probe for the Study of Respiratory Syncytial Virus Infection
. Journal of Medicinal Chemistry 55:20, pages 8582-8587.
Crossref
Crossref
Erik De Clercq. (2010) The next ten stories on antiviral drug discovery (part E): advents, advances, and adventures. Medicinal Research Reviews 31:1, pages 118-160.
Crossref
Crossref
John P. DeVincenzo, Tom Wilkinson, Akshay Vaishnaw, Jeff Cehelsky, Rachel Meyers, Saraswathy Nochur, Lisa Harrison, Patricia Meeking, Alex Mann, Elizabeth Moane, John Oxford, Rajat Pareek, Ryves Moore, Ed Walsh, Robert Studholme, Preston Dorsett, Rene Alvarez & Robert Lambkin-Williams. (2010) Viral Load Drives Disease in Humans Experimentally Infected with Respiratory Syncytial Virus. American Journal of Respiratory and Critical Care Medicine 182:10, pages 1305-1314.
Crossref
Crossref
Malcolm Carter & G. Stuart Cockerill. 2008.
229
248e
.
Erik De Clercq. 2007.
59
112
.
Robert W. Sidwell & Dale L. Barnard. (2006) Respiratory syncytial virus infections: Recent prospects for control. Antiviral Research 71:2-3, pages 379-390.
Crossref
Crossref